# Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

> **NCT04380142** · PHASE3 · COMPLETED · sponsor: **AbbVie** · enrollment: 174 (actual)

## Conditions studied

- Parkinson's Disease (PD)

## Interventions

- **DRUG:** ABBV-951
- **DRUG:** Placebo for Levodopa/Carbidopa (LD/CD)
- **DRUG:** Levodopa/Carbidopa (LD/CD)
- **DRUG:** Placebo for ABBV-951

## Key facts

- **NCT ID:** NCT04380142
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2021-09-29
- **Final completion:** 2021-09-29
- **Target enrollment:** 174 (ACTUAL)
- **Last updated:** 2022-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04380142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04380142, "Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04380142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*